A PCa methylation assay (ProCaMTM) assessing GSTP1, APC and RAR in urine has been validated in a multicenter prospective study in which urine samples from men with serum prostate PSA levels of 2.0–10.0 ng/ml were analyzed. Here, GSTP1 is linked to posterior cortical atrophy.